Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05351580 · ClinicalTrials.gov registry record
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 26
- Enrollment target
NCT05351580 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 26 participants.
The verdict
NCT05351580 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
To collect data to develop models that identify when patients with advanced Parkinson's disease (PD) are not responding well to their current therapy and may be ready to consider advanced therapy and when patients receiving advanced therapy are not responding well and need a therapy adjustment.
Interventions
- DEVICE DiSCERN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05351580
The ClinicalTrials.gov registry entry for NCT05351580 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DiSCERN is the first listed.
NCT05351580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05351580 about?
NCT05351580 is a clinical study titled "DiSCERN: Advanced PD Therapy Candidacy and Evaluation System". To collect data to develop models that identify when patients with advanced Parkinson's disease (PD) are not responding well to their current therapy and may be ready to consider advanced therapy and when patients receiving advanced therapy are not responding well and need a therapy adjustment.
What is the current status of trial NCT05351580?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2022-07-21. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05351580?
The interventions under investigation include: DiSCERN (DEVICE).
Who is sponsoring clinical trial NCT05351580?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.